{"symbol":"ABBV","fiscalQuarter":"Q2-2016","reportDate":"2016-07-29","reportTime":"BMO","status":"reported","company":{"name":"AbbVie Inc.","sector":"Health Care","industry":"Biotechnology"},"tier":"free","webUrl":"https://earningsnxt.ai/ticker/ABBV/earnings/Q2-2016","postBrief":{"headline":"AbbVie Beats on EPS, Stock Up 2.33%","keyNumbers":[{"metric":"EPS","actual":"$1.26","expected":"N/A","surprise":"+5.00%"},{"metric":"Revenue","actual":"N/A","expected":"N/A","surprise":"N/A"}],"managementCommentary":{"tone":"Unknown","keyQuotes":[],"summary":"No transcript is on record, and the analysis is based on numerical results only."},"guidanceChanges":{"summary":"No guidance data is available.","changes":[]},"whatItMeans":"AbbVie's earnings report shows a positive surprise on EPS, which likely contributed to the stock's increase of 2.33% on the day. However, without revenue figures or management commentary, investors may be cautious about the overall performance and future outlook. The lack of guidance also leaves uncertainty about the company's direction moving forward.","metaDescription":"AbbVie Inc. (ABBV) Q2 2016 earnings: EPS beat by 5.0%. Stock up 2.33%. Full breakdown."}}